Company: SXTPW
Filing Date: 2025-05-15
Form Type: 10-Q
Source: 0001213900-25-043779
Chunk: 11

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-05-15
Form: 10-Q
Item: Part I, Item 1
Chunk 11
---

assurance that the Company will be successful in raising additional capital or that such capital, if available, will be on terms that
are favorable to the Company. Debt financing and equity financing, if available, may involve agreements that include covenants limiting
or restricting the Company’s ability to take specific actions, such as incurring additional debt, making capital expenditures, or
declaring dividends. If the Company raises funds through collaborations, or other similar arrangements with third parties, it may have
to relinquish valuable rights to its technologies, future revenue streams, research programs or product candidates or grant licenses on
terms that may not be favorable to the Company and/or may reduce the value of its common stock. If the Company is unable to raise additional
funds through equity or debt financings when needed, it may be required to delay, limit, reduce or terminate its product development or
future commercialization efforts or grant rights to develop and market its product candidates even if the Company would otherwise prefer
to develop and market such product candidates itself.

As such, management concluded that such plans
do not alleviate the substantial doubt about the ability of the Company to continue as a going concern for one year from the date these
consolidated condensed financial statements are issued.

The consolidated condensed financial statements
have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of obligations in the normal
course of business, and do not include any adjustments to the amount and classification of assets and liabilities that may be necessary
should the Company be unable to continue as a going concern.

2. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation

The financial statements of 60P and its subsidiary
are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). The
Company has prepared the accompanying consolidated condensed financial statements pursuant to the instructions to Form 10-Q and Article
8 of Regulation S-X of the Securities and Exchange Commission (“SEC”). These financial statements are unaudited and, in the
opinion of management, all adjustments considered necessary for a fair presentation of the Company’s financial position, results
of operations, and cash flows have been included and are of a normal and recurring nature. Operating results for the periods presented
are not necessarily indicative of the results that may be expected for the year ending December 31, 2025 due to various factors. These
consolidated condensed financial statements should be read in conjunction with the audited